National Diabetes Prevention Program Funding

The Society is a leading advocate for funding for the NDPP, a program that uses lifestyle intervention to prevent or delay the onset of diabetes among individuals with prediabetes. The Society has advocated for increased funding for the program on Capitol Hill and with U.S. Surgeon General Vivek Murthy.

With support from the Society, the Chairs of the Congressional Diabetes Caucus (CDC) recently circulated a “Dear Colleague” letter requesting support for prioritizing funding for the National Institute for Diabetes and Digestive and Kidney Diseases, the CDC’s Division of Diabetes Translation, and the NDPP.

The NDPP has demonstrated great success through its expansion to over 794 sites in 39 states, and it could save the country as much as $190 billion if fully expanded. A testament to this success is the launch of an initiative from the CDC and the American Medical Association called, Prevent Diabetes STAT: Screen, Test, Act–Today. The initiative intends to raise awareness about prediabetes and increase screening and referral to evidence-based diabetes prevention programs that are a part of the NDPP.

You may also like

  • Endocrine Society Advocacy Updates

    Endocrine Society Endorses Right to IVF Act  In June 2024, the Endocrine Society endorsed the Right to IVF Act, introduced by Senators Cory Booker (D-NJ), Patty Murray (D-WA), and Tammy Duckworth (D-IL) to protect and expand nationwide access to fertility treatment, including in vitro fertilization (IVF). The Right to IVF Act would help individuals and families…

  • August 2024 Endocrine Society Advocacy Update

    Revised Version of TROA Passes House Ways & Means Committee On June 27, 2024, the House Ways and Means Committee passed a revised version of the Treat and Reduce Obesity Act (TROA), legislation that would allow Medicare coverage of anti-obesity medications (AOMs), which currently is prohibited under law. The version that passed would only allow…